Sebrell, T. Andrew
Sidar, Barkan
Bruns, Rachel
Wilkinson, Royce A.
Wiedenheft, Blake
Taylor, Paul J.
Perrino, Brian A.
Samuelson, Linda C.
Wilking, James N.
Bimczok, Diane
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R03 DK107960)
NIH Office of the Director (R44 OD012083)
National Institute of General Medical Sciences (GM110732)
M.J. Murdock Charitable Trust
National Science Foundation (DMR-1455247)
Montana University System Research Initiative (MUSRI2015-03)
Article History
Received: 31 March 2017
Accepted: 27 October 2017
First Online: 25 November 2017
Compliance with ethical standards
:
: Dr. Paul Taylor has a potential conflict of interest, since he is the owner of GeneSearch, Inc., Bozeman, MT, which manufactures the EmbryoCradle microinjector that was used in this study. None of the other authors declare a conflict of interest.